What Alnylam Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 1 | 279 |
| Total trades | 2 | 321 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 107 | 172,803 |
| Disposed | 1,758 | 120,661 |
| Net activity | −1,651 | +52,142 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Supran Bryan | EVP, CLO and Secretary | Oct 02 | Open-market sale · S | −1,758 | $226.88 | −$399K | 12,807 |
| Greenstreet Yvonne | Chief Executive Officer | Sep 19 | Grant / award · A | +107 | — | — | 95,802 |
| Pyott David E I | Director | Jun 01 | Open-market sale · S | −17 | $302.65 | −$5.15K | 1,582 |
| Pyott David E I | Director | Jun 01 | Open-market sale · S | −495 | $300.72 | −$149K | 1,599 |
| Pyott David E I | Director | Jun 01 | Open-market sale · S | −1,222 | $299.87 | −$366K | 2,094 |
| Pyott David E I | Director | Jun 01 | Open-market sale · S | −1,175 | $298.91 | −$351K | 3,316 |
| Pyott David E I | Director | Jun 01 | Open-market sale · S | −921 | $297.71 | −$274K | 4,491 |
| Pyott David E I | Director | Jun 01 | Exercise / conversion · M | +3,830 | — | — | 5,412 |
| Arbuckle Stuart A | Director | May 20 | Grant / award · A | +671 | — | — | 671 |
| Ausiello Dennis A | Director | May 20 | Grant / award · A | +671 | — | — | 1,582 |
| Hamburg Margaret A | Director | May 20 | Grant / award · A | +671 | — | — | 1,582 |
| Brandicourt Olivier | Director | May 20 | Grant / award · A | +671 | — | — | 1,446 |
| Pyott David E I | Director | May 20 | Grant / award · A | +671 | — | — | 1,582 |
| Kellogg Peter N | Director | May 20 | Grant / award · A | +671 | — | — | 1,446 |
| Reitan Colleen F | Director | May 20 | Grant / award · A | +671 | — | — | 1,446 |
| Schulman Amy W | Director | May 20 | Grant / award · A | +838 | — | — | 24,049 |
| Sigal Charles Elliott | Director | May 20 | Grant / award · A | +671 | — | — | 1,446 |
| Schulman Amy W | Director | May 13 | Exercise / conversion · M | +11,250 | $70.20 | +$790K | 23,211 |
| McLaughlin Melissa | Chief Human Resources Officer | Apr 06 | Open-market sale · S | −199 | $333.94 | −$66.5K | 9,443 |
| McLaughlin Melissa | Chief Human Resources Officer | Apr 06 | Open-market sale · S | −293 | $331.89 | −$97.2K | 9,642 |
Loading...
